Financhill
Sell
47

NIO Quote, Financials, Valuation and Earnings

Last price:
$4.53
Seasonality move :
-19.03%
Day range:
$4.42 - $4.61
52-week range:
$3.61 - $9.57
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.02x
P/B ratio:
5.87x
Volume:
35.6M
Avg. volume:
55.9M
1-year change:
-42.68%
Market cap:
$9.5B
Revenue:
$7.9B
EPS (TTM):
-$1.50
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $1.1B $2.4B $5.6B $7.3B $7.9B
Revenue Growth (YoY) 51.25% 107.96% 137.57% 31.06% 7.2%
 
Cost of Revenues $1.3B $2.1B $4.5B $6.6B $7.4B
Gross Profit -$173.6M $271.5M $1.1B $765.8M $431.4M
Gross Profit Margin -15.32% 11.52% 18.88% 10.44% 5.49%
 
R&D Expenses $641.1M $360.5M $711.2M $1.6B $1.9B
Selling, General & Admin $707.4M $511.1M $973.8M $1.4B $1.7B
Other Inc / (Exp) $243.5K -$62.4M $38.3M $34.7M $55.1M
Operating Expenses $1.4B $939.1M $1.8B $3.1B $3.6B
Operating Income -$1.6B -$667.7M -$696.4M -$2.3B -$3.2B
 
Net Interest Expenses $30.4M $37.5M -- -- --
EBT. Incl. Unusual Items -$1.6B -$767.7M -$615.6M -$2.1B -$2.9B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $1.1M $922.8K $6.5M $8.2M $36.9M
Net Income to Company -$1.6B -$768.6M -$622.1M -$2.1B -$2.9B
 
Minority Interest in Earnings -$17M -$44.4M -$1B -$18.2M -$60.4M
Net Income to Common Excl Extra Items -$1.7B -$813M -$1.6B -$2.2B -$3B
 
Basic EPS (Cont. Ops) -$1.60 -$0.69 -$1.04 -$1.32 -$1.76
Diluted EPS (Cont. Ops) -$1.60 -$0.69 -$1.04 -$1.32 -$1.76
Weighted Average Basic Share $1B $1.2B $1.6B $1.6B $1.7B
Weighted Average Diluted Share $1B $1.2B $1.6B $1.6B $1.7B
 
EBITDA -$1.4B -$481.9M -$152.6M -$1.5B -$2.1B
EBIT -$1.6B -$705.9M -$516.9M -$2.1B -$2.8B
 
Revenue (Reported) $1.1B $2.4B $5.6B $7.3B $7.9B
Operating Income (Reported) -$1.6B -$667.7M -$696.4M -$2.3B -$3.2B
Operating Income (Adjusted) -$1.6B -$705.9M -$516.9M -$2.1B -$2.8B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $653.7M $1.5B $1.9B $2.6B $2.6B
Revenue Growth (YoY) 149.68% 131.63% 25.36% 38.82% -1.02%
 
Cost of Revenues $569.1M $1.2B $1.6B $2.4B $2.3B
Gross Profit $84.6M $307.8M $253.3M $210.5M $280.4M
Gross Profit Margin 12.94% 20.33% 13.35% 7.99% 10.75%
 
R&D Expenses $85.3M $184.2M $429.8M $420M $463.5M
Selling, General & Admin $135.8M $281.8M $396M $498.8M $573.9M
Other Inc / (Exp) -$6.2M -$472K -$64.7M $12.3M $15.4M
Operating Expenses $221.2M $460.9M $818.3M $879.9M $1B
Operating Income -$136.6M -$153.2M -$565M -$669.4M -$731.5M
 
Net Interest Expenses $8.2M -- -- -- --
EBT. Incl. Unusual Items -$151M -$128.5M -$598.7M -$629.5M -$701.3M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $175.2K $501.8K $1.4M $222.5K $5.3M
Net Income to Company -$565.5M -$289.3M -- -- --
 
Minority Interest in Earnings -$20.4M -$312.5M -$4.6M -$9.9M -$11.4M
Net Income to Common Excl Extra Items -$171.6M -$441.4M -$604.7M -$639.6M -$718.1M
 
Basic EPS (Cont. Ops) -$0.14 -$0.28 -$0.39 -$0.37 -$0.35
Diluted EPS (Cont. Ops) -$0.14 -$0.28 -$0.39 -$0.37 -$0.35
Weighted Average Basic Share $1.2B $1.6B $1.6B $1.7B $2.1B
Weighted Average Diluted Share $1.2B $1.6B $1.6B $1.7B $2.1B
 
EBITDA -$135.3M -$116.6M -$584M -$617.2M -$672.9M
EBIT -$135.3M -$116.6M -$584M -$617.2M -$672.9M
 
Revenue (Reported) $653.7M $1.5B $1.9B $2.6B $2.6B
Operating Income (Reported) -$136.6M -$153.2M -$565M -$669.4M -$731.5M
Operating Income (Adjusted) -$135.3M -$116.6M -$584M -$617.2M -$672.9M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $1.8B $5.1B $6.6B $7.7B $8.8B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $1.7B $4.1B $5.6B $7.4B $8B
Gross Profit $68.8M $963.2M $949.2M $334M $761M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $382.7M $551.9M $1.3B $1.9B $1.9B
Selling, General & Admin $608.9M $880.1M $1.4B $1.7B $1.9B
Other Inc / (Exp) $7.1M -$36M -$60.3M $114M $57.3M
Operating Expenses $995.1M $1.4B $2.7B $3.6B $3.9B
Operating Income -$926.3M -$457.4M -$1.7B -$3.2B -$3.1B
 
Net Interest Expenses $45.9M $3.7M -- -- --
EBT. Incl. Unusual Items -$965.1M -$497.2M -$1.6B -$3B -$2.8B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $1M $1.6M $11.1M $6.4M $39M
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -$33.3M -$1B -$15M -$37.3M -$64.1M
Net Income to Common Excl Extra Items -$999.5M -$1.5B -$1.6B -$3B -$2.9B
 
Basic EPS (Cont. Ops) -$0.94 -$0.99 -$1.03 -$1.82 -$1.50
Diluted EPS (Cont. Ops) -$0.94 -$0.99 -$1.03 -$1.82 -$1.50
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -$829M -$331.3M -$1.5B -$2.9B -$2.7B
EBIT -$903.1M -$396.4M -$1.6B -$2.9B -$2.7B
 
Revenue (Reported) $1.8B $5.1B $6.6B $7.7B $8.8B
Operating Income (Reported) -$926.3M -$457.4M -$1.7B -$3.2B -$3.1B
Operating Income (Adjusted) -$903.1M -$396.4M -$1.6B -$2.9B -$2.7B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $1.4B $4.1B $5B $5.4B $6.4B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $1.3B $3.3B $4.3B $5.2B $5.8B
Gross Profit $104.8M $791M $683.7M $246.6M $583.3M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $237M $426.8M $1B $1.3B $1.3B
Selling, General & Admin $389.4M $698.1M $1.1B $1.3B $1.5B
Other Inc / (Exp) $893.6K $30.1M -$68.4M $14.9M $17.5M
Operating Expenses $629.9M $1.1B $2B $2.5B $2.8B
Operating Income -$525.1M -$316.9M -$1.3B -$2.3B -$2.2B
 
Net Interest Expenses $34.6M $46.9M -- -- --
EBT. Incl. Unusual Items -$558.8M -$288M -$1.3B -$2.2B -$2.1B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $670.8K $1.4M $5.9M $4M $6.6M
Net Income to Company -$565.5M -$289.3M -$686.8M -$1.5B --
 
Minority Interest in Earnings -$29.2M -$1B -$9.4M -$28.7M -$32.9M
Net Income to Common Excl Extra Items -$588.7M -$1.3B -$1.3B -$2.2B -$2.2B
 
Basic EPS (Cont. Ops) -$0.54 -$0.83 -$0.82 -$1.32 -$1.06
Diluted EPS (Cont. Ops) -$0.54 -$0.83 -$0.82 -$1.32 -$1.06
Weighted Average Basic Share $3.3B $4.7B $4.9B $5B $6.1B
Weighted Average Diluted Share $3.3B $4.7B $4.9B $5B $6.1B
 
EBITDA -$511.3M -$201.4M -$1.3B -$2.1B -$2B
EBIT -$511.3M -$201.4M -$1.3B -$2.1B -$2B
 
Revenue (Reported) $1.4B $4.1B $5B $5.4B $6.4B
Operating Income (Reported) -$525.1M -$316.9M -$1.3B -$2.3B -$2.2B
Operating Income (Adjusted) -$511.3M -$201.4M -$1.3B -$2.1B -$2B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $123.3M $5.9B $2.4B $2.9B $4.6B
Short Term Investments $15.9M $604.7M $5.8B $2.8B $2.4B
Accounts Receivable, Net $193.2M $172M $438.9M $741.8M $657.1M
Inventory $127.1M $165.5M $322.6M $1.2B $744.5M
Prepaid Expenses $23.2M $19.8M $39.5M $129.2M $115.1M
Other Current Assets -- -$6.8M -- -- --
Total Current Assets $704.3M $7.1B $10B $8.6B $9.9B
 
Property Plant And Equipment $1.1B $988.4M $1.7B $3.4B $5.3B
Long-Term Investments $16.5M $45.9M $480M $921.3M $774.1M
Goodwill -- -- -- -- --
Other Intangibles $30.1M $31.3M $31.2M $30.8M $33.4M
Other Long-Term Assets $17M $8.5M $1.8M $19.5M $22.5M
Total Assets $2.1B $8.4B $13B $14B $16.6B
 
Accounts Payable $444.7M $974.7M $2B $1.8B $2B
Accrued Expenses $50.3M $57M $84.5M $243.9M $152.3M
Current Portion Of Long-Term Debt $145.8M $58.2M $324.4M $179.4M $710.8M
Current Portion Of Capital Lease Obligations $92.8M $88.8M $121.2M $153.1M $249.5M
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $1.4B $2.1B $4.6B $6.6B $8.2B
 
Long-Term Debt $1B $908.9M $1.5B $1.6B $1.8B
Capital Leases -- -- -- -- --
Total Liabilities $3B $3.5B $7.5B $10.5B $12.9B
 
Common Stock $261.1K $410.1K $453.7K $423.5K $511K
Other Common Equity Adj -$29M -$10M -$43.3M $150.2M $61.1M
Common Equity -$900.4M $4.2B $5.4B $3.5B $3.6B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $3.2M $718.4M $11.9M $32.1M $26.7M
Total Equity -$897.2M $4.9B $5.5B $3.5B $3.6B
 
Total Liabilities and Equity $2.1B $8.4B $13B $14B $16.6B
Cash and Short Terms $139.2M $6.5B $8.2B $5.7B $7B
Total Debt $1.2B $1.2B $2.7B $4.2B $5.4B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $2.8B $3.3B $2.5B $3.3B $3.4B
Short Term Investments $398.2M $3.4B $3.8B $2B $1.9B
Accounts Receivable, Net $222.7M $506.5M $615.2M $736.3M $271.5M
Inventory $152.2M $263.2M $936.2M $968.1M $972.4M
Prepaid Expenses $18.9M $39.3M -- -- --
Other Current Assets -$6M -- $272.9M $435.4M $590.5M
Total Current Assets $3.9B $8.4B $8.8B $8.3B $8.6B
 
Property Plant And Equipment $972.1M $1.3B $2.8B $4.2B $5.2B
Long-Term Investments $49.9M $202.1M $839.6M $758.3M $532.2M
Goodwill -- -- -- -- --
Other Intangibles $30.2M $31M $30M $32.7M $33.2M
Other Long-Term Assets $12M $1.6M $1B $775.6M $493.4M
Total Assets $5B $10.7B $13.6B $14B $14.8B
 
Accounts Payable $722.5M $1.7B $2.9B $3.9B $4.3B
Accrued Expenses $46.2M $56.9M $1.5B $2B $2.1B
Current Portion Of Long-Term Debt $133.3M $241.5M $955.3M $1.4B $1.5B
Current Portion Of Capital Lease Obligations $81.1M $104.2M $116.7M $185.4M $254.1M
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $1.6B $4.1B $5.6B $7.6B $8.2B
 
Long-Term Debt $991M $1.5B $1.8B $1.7B $1.6B
Capital Leases -- -- -- -- --
Total Liabilities $3.9B $6.9B $9B $11.3B $12.5B
 
Common Stock $353.6K $433.9K -- -- --
Other Common Equity Adj -$14.4M -$36.2M -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $642.2K $15.8M $523.5M $545.6M $673.6M
Total Equity $1.2B $3.8B $4.6B $2.7B $2.3B
 
Total Liabilities and Equity $5B $10.7B $13.6B $14B $14.8B
Cash and Short Terms $3.2B $6.7B $6.3B $5.3B $5.3B
Total Debt $1.2B $2.6B $2.7B $3B $3.1B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders -$1.6B -$768.6M -$622.1M -$2.1B -$2.9B
Depreciation & Amoritzation $220.2M $224M $364.3M $594.6M $693.8M
Stock-Based Compensation $48.3M $27.1M $156.5M $341.8M $334.9M
Change in Accounts Receivable -$97.3M $17.2M -$489.7M -$317.9M $17.5M
Change in Inventories $82.4M -$28.7M -$153.4M -$931.6M $409.3M
Cash From Operations -$1.3B $282.7M $304.6M -$575.6M -$195.3M
 
Capital Expenditures $247.1M $163.4M $631.7M $1B $2B
Cash Acquisitions $6.5M -$36.3M -$91.8M $1.1M -$59.6M
Cash From Investing $489.6M -$734.8M -$6.2B $1.5B -$1.5B
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $825.1M $720.3M $2.4B $1B $2.3B
Long-Term Debt Repaid -$384.4M -$187.4M -$381.8M -$1.3B -$1.3B
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- $422.8M -$1.2B -$5.3M -$35.3K
Cash From Financing $448.1M $6B $2.8B -$240.6M $3.9B
 
Beginning Cash (CF) $466.8M $143.4M $6B $2.7B $3.3B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$325M $5.5B -$3B $729.9M $2.2B
Ending Cash (CF) $143.3M $5.6B $2.8B $3.4B $5.5B
 
Levered Free Cash Flow -$1.5B $119.3M -$327.2M -$1.6B -$2.2B
Period Ending 2019-06-30 2020-06-30 2021-06-30 2022-06-30 2023-06-30
Net Income to Stockholders -- -- -- -$686.8M -$1.5B
Depreciation & Amoritzation -- -- -- $244.6M $291M
Stock-Based Compensation -- -- -- $145.8M $171.1M
Change in Accounts Receivable -- -- -- -$55.7M -$92.8M
Change in Inventories -- -- -- -$197.8M -$27.7M
Cash From Operations -- -- -- -$204M -$1.7B
 
Capital Expenditures -- -- -- $523.9M $718.9M
Cash Acquisitions -- -- -- -$14.5M -$24.3M
Cash From Investing -- -- -- $1.3B $316.3M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- $924.1M $885.2M
Long-Term Debt Repaid -- -- -- -$510.1M -$594.6M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -$3.8M --
Cash From Financing -- -- -- $415.2M $292.9M
 
Beginning Cash (CF) -- -- -- $2.8B $3.3B
Foreign Exchange Rate Adjustment -- -- -- $9.2M $20.2M
Additions / Reductions -- -- -- $1.5B -$1B
Ending Cash (CF) -- -- -- $4.3B $2.3B
 
Levered Free Cash Flow -- -- -- -$727.9M -$2.4B
Period Ending 2020-03-31 2021-03-31 2022-03-31 2023-03-31 2024-03-31
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation $40.2M $18.3M $94.7M $145.8M $171.1M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- --
 
Capital Expenditures $211.8M $137.5M $369.8M $523.9M $718.9M
Cash Acquisitions -$2.4M -$37.2M -$45.4M -$14.5M -$24.3M
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- --
Period Ending 2020-06-30 2021-06-30 2022-06-30 2023-06-30 2024-06-30
Net Income to Stockholders -- -- -$686.8M -$1.5B --
Depreciation & Amoritzation -- -- $244.6M $291M --
Stock-Based Compensation -- -- $145.8M $171.1M --
Change in Accounts Receivable -- -- -$55.7M -$92.8M --
Change in Inventories -- -- -$197.8M -$27.7M --
Cash From Operations -- -- -$204M -$1.7B --
 
Capital Expenditures -- -- $523.9M $718.9M --
Cash Acquisitions -- -- -$14.5M -$24.3M --
Cash From Investing -- -- $1.3B $316.3M --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- $924.1M $885.2M --
Long-Term Debt Repaid -- -- -$510.1M -$594.6M --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -$3.8M -- --
Cash From Financing -- -- $415.2M $292.9M --
 
Beginning Cash (CF) -- -- $2.8B $3.3B --
Foreign Exchange Rate Adjustment -- -- $9.2M $20.2M --
Additions / Reductions -- -- $1.5B -$1B --
Ending Cash (CF) -- -- $4.3B $2.3B --
 
Levered Free Cash Flow -- -- -$727.9M -$2.4B --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock